BenevolentAI
our mission uniting human and intelligence to discover new ways to treat disease is at the forefront of a revolution in drug discovery and development as research and data expand exponentially the opportunity emerges to understand biology better we combine advanced and machine learning with cutting edge science to decipher complex disease biology and discover optimum therapeutic interventions artificial | BenevolentAI
Company
Deck Type
Deck date
December 2021
Slide
7 of 42
Other recent decks by BenevolentAI
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io